SE7705934L - Forfarande for framstellning av cefalosporiner - Google Patents

Forfarande for framstellning av cefalosporiner

Info

Publication number
SE7705934L
SE7705934L SE7705934A SE7705934A SE7705934L SE 7705934 L SE7705934 L SE 7705934L SE 7705934 A SE7705934 A SE 7705934A SE 7705934 A SE7705934 A SE 7705934A SE 7705934 L SE7705934 L SE 7705934L
Authority
SE
Sweden
Prior art keywords
cephalosporins
procedure
preparation
Prior art date
Application number
SE7705934A
Other languages
English (en)
Other versions
SE433851B (sv
Inventor
G Palamidessi
F Zarini
G Franceschi
G Schioppacassi
F Arcamone
Original Assignee
Farmaceutici Italia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmaceutici Italia filed Critical Farmaceutici Italia
Publication of SE7705934L publication Critical patent/SE7705934L/sv
Publication of SE433851B publication Critical patent/SE433851B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7705934A 1976-05-21 1977-05-18 Forfarande for framstellning av cefalosporinderivat SE433851B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB21032/76A GB1579532A (en) 1976-05-21 1976-05-21 Cephalosporins

Publications (2)

Publication Number Publication Date
SE7705934L true SE7705934L (sv) 1977-11-22
SE433851B SE433851B (sv) 1984-06-18

Family

ID=10156029

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7705934A SE433851B (sv) 1976-05-21 1977-05-18 Forfarande for framstellning av cefalosporinderivat

Country Status (22)

Country Link
US (1) US4148996A (sv)
JP (1) JPS52142093A (sv)
AT (1) AT355719B (sv)
AU (1) AU509448B2 (sv)
BE (1) BE854845A (sv)
CA (1) CA1102790A (sv)
CH (1) CH639095A5 (sv)
CS (1) CS199676B2 (sv)
DE (1) DE2722666C2 (sv)
DK (1) DK216877A (sv)
FR (1) FR2424922A1 (sv)
GB (1) GB1579532A (sv)
GR (1) GR73013B (sv)
HU (1) HU174072B (sv)
IL (1) IL52123A (sv)
NL (1) NL7705262A (sv)
NO (1) NO771744L (sv)
NZ (1) NZ184110A (sv)
SE (1) SE433851B (sv)
SU (1) SU799669A3 (sv)
YU (1) YU123077A (sv)
ZA (1) ZA772859B (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017004077A1 (en) * 2015-06-29 2017-01-05 Duke University Antimicrobial prochelators to target drug-resistant bacteria and methods of making and using the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL38099A (en) * 1970-12-17 1976-01-30 Smith Kline French Lab 3-heterocyclyl thiomethylcephalosporins
US4007173A (en) * 1973-05-07 1977-02-08 Smithkline Corporation α-amino-α-(ureidophenyl)acetamidocephalosporins
DE2359544A1 (de) * 1973-11-29 1975-10-30 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
US3960849A (en) * 1974-03-13 1976-06-01 E. R. Squibb & Sons, Inc. Amino-1,2,4-oxadiazolyl-3-acetyl cephalosporins
DE2512284A1 (de) * 1974-03-28 1975-10-09 Fujisawa Pharmaceutical Co Cephalosporansaeurederivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel

Also Published As

Publication number Publication date
IL52123A (en) 1980-11-30
CS199676B2 (en) 1980-07-31
FR2424922B1 (sv) 1983-07-08
HU174072B (hu) 1979-10-28
JPS52142093A (en) 1977-11-26
BE854845A (fr) 1977-11-21
IL52123A0 (en) 1977-07-31
FR2424922A1 (fr) 1979-11-30
SE433851B (sv) 1984-06-18
AT355719B (de) 1980-03-25
ATA348977A (de) 1979-08-15
YU123077A (en) 1982-10-31
SU799669A3 (ru) 1981-01-23
DE2722666A1 (de) 1977-12-01
NL7705262A (nl) 1977-11-23
US4148996A (en) 1979-04-10
ZA772859B (en) 1978-04-26
DE2722666C2 (de) 1982-04-15
AU2507177A (en) 1978-11-16
CH639095A5 (de) 1983-10-31
DK216877A (da) 1977-11-22
GB1579532A (en) 1980-11-19
NZ184110A (en) 1979-08-31
NO771744L (no) 1977-11-22
GR73013B (sv) 1984-01-25
AU509448B2 (en) 1980-05-15
CA1102790A (en) 1981-06-09

Similar Documents

Publication Publication Date Title
SE441827B (sv) Forfarande for framstellning av fenoxiaminopropanoler
SE435059B (sv) Forfarande for framstellning av med kveveheterocykliska grupper substituerade 1-fenyl-2-alkylaminoetanol-foreningar
NO774404L (no) Fremgangsmaate for fremstilling av dimetyleter
SE437515B (sv) Forfarande for framstellning av nya fenyletylaminer
SE441354B (sv) Forfarande for framstellning av meta-fenoxibensaldehyd
SE435387B (sv) Forfarande for framstellning av antracyklinglykosider
NO143992C (no) Fremgangsmaate for fremstilling av heksanitrostilben
NO821848L (no) Fremgangsmaate for fremstilling av gamma-pyron-derivater
SE7702332L (sv) Forfarande for framstellning av cefalosporinforeningar
SE7614264L (sv) Forfarande for framstellning av nya 17-estrar av 17alfa-hydroxigestogener
NO774067L (no) Fremgangsmaate for fremstilling av cellulosemasse
SE441359B (sv) Forfarande for framstellning av nya klavulansyratioetrar
NO772960L (no) Fremgangsmaate til fremstilling av cefalosporinderivater
SE7707471L (sv) Forfarande for framstellning av 5-m-tolyloxiuracil
SE434263B (sv) Forfarande for framstellning av kloretylnitrosokarbamider med antitumorverkan
SE7712218L (sv) Forfarande for framstellning av 4a-aryloktahydro-1h-2-pyrindiner
SE435380B (sv) Forfarande for framstellning av kinazolinforeningar
SE7709636L (sv) Forfarande for framstellning av 4-oxokapronitril
SE7709142L (sv) Forfarande for framstellning av 1-aryloxi-3-amino-propan-2-oler
SE7702071L (sv) Forfarande for framstellning av sulfoacetaler
SE7714872L (sv) Forfarande for framstellniong av halogenacylamider
SE7701667L (sv) Forfarande for framstellning av cefalosporin-antibiotika
SE436496B (sv) Forfarande for framstellning av dibensotiofenderivat
SE7700572L (sv) Forfarande for framstellning av tienopyridinderivat
SE416545B (sv) Forfarande for framstellning av nya hjertaktiva 1-frnoxi-3-aminopropan-2-ol-derivat